DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



A Comparative Study of Ampicillin/Sulbactam Versus Moxifloxacin in the Treatment of Complicated Intra-abdominal Infections

Information source: Kaohsiung Medical University Chung-Ho Memorial Hospital
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Intra-abdominal Infection

Intervention: moxifloxacin (Drug); ampicillin/sulbactam (Drug)

Phase: Phase 4

Status: Completed

Sponsored by: Kaohsiung Medical University Chung-Ho Memorial Hospital

Summary

On the basis of monotherapy for intra-abdominal infection, the investigators are conducting this study to identify the difference of drug efficacy between ampicillin/sulbactam and moxifloxacin.

Clinical Details

Official title: A Comparative Study of Ampicillin/Sulbactam Versus Moxifloxacin in the Treatment of Complicated Intra-abdominal Infections

Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment

Primary outcome: clinical response at test-of-cure visit

Eligibility

Minimum age: N/A. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- patients diagnosed of complicated intra-abdominal infection need surgical treatment

Exclusion Criteria:

- patients diagnosed of intra-abdominal infection receive non-operative management

- patients with known allergic history of fluoroquinolone

- Severe, life threatening disease with a life expectancy of < 48 h or APS and APACHE

scores of > 35

Locations and Contacts

Kaohsiung Medical University Hospital, Department of Emergency Medicine/Surgery, Kaohsiung 804, Taiwan
Additional Information

Starting date: January 2009
Last updated: August 1, 2011

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015